Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 971-975

  Lim, Wan Teck ^a   Chuah, Khoon Leong ^b   Leong, Swan Swan ^a   Tan, Eng Huat ^a   Toh, Chee Keong ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Epstein Barr virus; Human papillomavirus; Lung adenocarcinoma

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFECTION RISK; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VIRUS INFECTION; WART VIRUS; ADENOCARCINOMA; GENETICS; ISOLATION AND PURIFICATION; LUNG TUMOR; MIDDLE AGED; PAPILLOMA VIRUS; VIROLOGY;

CD69 ANTIGEN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADENOCARCINOMA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; RNA, VIRAL;

EID: 67449098971     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000310     Document Type: Article

References (40)

1. Hopkins JM and Evans HJ: Cigarette smoke-induced DNA damage and lung cancer risks. Nature 283: 388-390, 1980.
2. Lam B, Lam WK, Lam CL, Ooi GC, Ho JC, Wong MP and Tsang KW: Adenocarcinoma of the lung in Chinese patients: a revisit and some perspectives from the literature. Postgrad Med J 77: 708-712, 2001.
3. Seow A, Poh WT, Teh M, et al: Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 9: 1215-1221, 2000.
4. Li S, Pan D and Wang G: Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes. Arch Environ Health 49: 119-122, 1994.
5. Zhao B, Seow A, Lee EJ, et al: Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 10: 1063-1067, 2001.
6. Ng DP, Tan KW, Zhao B and Seow A: CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 16: 399-405, 2005.
7. Chen S, Xue K, Xu L, Ma G and Wu J: Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res 458: 41-47, 2001.
8. Syrjanen KJ: HPV infections and lung cancer. J Clin Pathol 55: 885-891, 2002.
9. Brousset P, Butet V, Chittal S, Selves J and Delsol G: Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab Invest 67: 457-464, 1992.
10. Bewtra C, Xie Q, Soundararajan S, Gatalica Z and Hatcher L: Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies. Acta Cytol 49: 127-131, 2005.
11. Iftner T and Villa LL: Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 31: 80-88, 2003.
12. Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM and Zheng ZM: Could human papillomaviruses be spread through blood? J Clin Microbiol 43: 5428-5434, 2005.
13. Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Shaji RV and Chandy G: HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol 3: 204-209, 2004.
14. Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY and Lee H: The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97: 1558-1563, 2003.
15. Chow VT, Tham KM, Lim-Tan SK, Sng IT and Bernard HU: Genital human papillomavirus infection among women from major ethnic groups in Singapore. Asia Oceania J Obstet Gynaecol 16: 373-377, 1990.
16. Clifford GM, Gallus S, Herrero R, et al: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998, 2005.
17. Bao YP, Li N, Smith JS, Qiao YL, ACCPAB Members: Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18: 71-79, 2008.
18. Cook JR, Hill DA, Humphrey PA, Pfeifer JD and El-Mofty SK: Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 13: 914-918, 2000.
19. Kaya H, Kotiloglu E, Inanli S, Ekicioglu G, Bozkurt SU, Tutkun A and Kullu S: Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 93: 531-534, 2001.
20. Gorgoulis VG, Zacharatos P, Kotsinas A, et al: Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30: 274-283, 1999.
21. Szabo I, Sepp R, Nakamoto K, Maeda M, Sakamoto H and Uda H: Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 73: 2740-2744, 1994.
22. Aguayo F, Castillo A, Koriyama C, et al: Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 97: 85-91, 2007.
23. Noutsou A, Koffa M, Egrazaki M, Siafakas NM and Spandidos DA: Detection of human papillomavirus (HPV) and K-ras mutations in human lung carcinomas. Int J Oncol 8: 1089-1093, 1996.
24. Giuliani L, Jaxmar T, Casadio C, et al: Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57: 273-281, 2007.
25. Kinoshita I, Dosaka-Akita H, Shindoh M, et al: Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 71: 344-349, 1995.
26. Tsuhako K, Nakazato I, Hirayasu T, Sunakawa H and Iwamasa T: Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 51: 741-749, 1998.
27. Iwamasa T, Miyagi J, Tsuhako K, Kinjo T, Kamada Y, Hirayasu T and Genka K: Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol Res Pract 196: 209-218, 2000.
28. Cheng YW, Chiou HL, Sheu GT, et al: The association of human papillomavirus 16/18 infection with lung cancer among non-smoking Taiwanese women. Cancer Res 61: 2799-2803, 2001.
29. Fei Y, Yang J, Hsieh WC, et al: Different human papillomavirus 16/ 18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 36: 274-279, 2006.
30. Park MS, Chang YS, Shin JH, et al: The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 48: 69-77, 2007.
31. Jain N, Singh V, Hedau S, et al: Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128: 3999-4007, 2005.
32. Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P and Degano B: Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92: 743-746, 2005.
33. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL and Clavel CE: Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18: 1606-1609, 2005.
34. Clavel CE, Nawrocki B, Bosseaux B, et al: Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 88: 1347-1352, 2000.
35. Henderson BE, Louie EW, Jing JS and Alena B: Epstein-Barr virus and nasopharyngeal carcinoma: is there an etiologic relationship? J Natl Cancer Inst 59: 1393-1395, 1977.
36. Ambinder RF and Mann RB: Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 145: 239-252, 1994.
37. Han AJ, Xiong M and Zong YS: Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China. Am J Clin Pathol 114: 220-226, 2000.
38. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E and Gould VE: Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 62: 4876-4878, 2002.
39. Chu PG, Cerilli L, Chen YY, Mills SE and Weiss LM: Epstein-Barr virus plays no role in the tumorigenesis of small-cell carcinoma of the lung. Mod Pathol 17: 158-164, 2004.
40. Conway EJ, Hudnall SD, Lazarides A, Bahler A, Fraire AE and Cagle PT: Absence of evidence for an etiologic role for Epstein-Barr virus in neoplasms of the lung and pleura. Mod Pathol 9: 491-495, 1996.